GPAT is an innovative study of group Psilocybin Assisted Therapy using an affinity group model including veteran/first responders, women survivors of sexual trauma, and other groups. Preferred ...
GPAT is an innovative study of group Psilocybin Assisted Therapy using an affinity group model including veteran/first responders, women survivors of sexual trauma, and other groups. Preferred ...
GPAT is an innovative study of group Psilocybin Assisted Therapy using an affinity group model including veteran/first responders, women survivors of sexual trauma, and other groups. Preferred ...
GPAT is an innovative study of group Psilocybin Assisted Therapy using an affinity group model including veteran/first responders, women survivors of sexual trauma, and other groups. Preferred ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
Quick apply
Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress ...
psilocybin information
See salary details
$8.89 - $13.70
16% of jobs
$15.17 is the 25th percentile. Wages below this are outliers.
$13.70 - $18.51
29% of jobs
The median wage is $19.71 / hr.
$18.51 - $23.32
19% of jobs
$27.58 is the 75th percentile. Wages above this are outliers.
$23.32 - $28.13
12% of jobs
$28.13 - $32.93
8% of jobs
$32.93 - $37.74
5% of jobs
$37.74 - $42.55
4% of jobs
$42.55 - $47.36
2% of jobs
$47.36 - $52.16
2% of jobs
$52.16 - $56.97
1% of jobs
$56.97 - $61.78
1% of jobs
$8
$26
$61
How much do psilocybin jobs pay per hour?
What is a psilocybin facilitator?
A Psilocybin job typically involves working in research, therapy, cultivation, or policy related to psilocybin, a psychedelic compound found in certain mushrooms. Professionals in this field may study its effects, facilitate therapeutic sessions, or advocate for legal reforms. Roles can include clinical therapists, mycologists, policy advocates, and lab researchers. With growing interest in psychedelic-assisted therapy, careers in psilocybin are expanding in both clinical and scientific settings.
What are the key responsibilities and challenges for professionals working in psilocybin-assisted therapy programs?
What are the key skills and qualifications needed to thrive as a psilocybin facilitator, and why are they important?
What is the difference between Psilocybin vs Clinical Psychologist?
| Aspect | Psilocybin | Clinical Psychologist |
|---|---|---|
| Required Credentials | Research approval, medical supervision | Doctoral degree (PhD or PsyD), licensure |
| Work Environment | Research labs, clinical trial settings | Clinics, hospitals, private practice |
| Industry Usage | Therapeutic research, mental health studies | Patient diagnosis, therapy, mental health treatment |
While Psilocybin is a psychedelic compound used in research and therapy settings, a Clinical Psychologist is a licensed mental health professional providing diagnosis and treatment. Psilocybin research often involves clinical psychologists, but they are distinct roles with different credentials and work environments.
How do I become a psilocybin therapist?
What cities are hiring for Psilocybin jobs?
Cities with the most Psilocybin job openings:
What are the most commonly searched types of Psilocybin jobs?
The most popular types of Psilocybin jobs are:
What states have the most Psilocybin jobs?
States with the most job openings for Psilocybin jobs include:
What job categories do people searching Psilocybin jobs look for?
The top searched job categories for Psilocybin jobs are:

Counselor/Social Worker,Sr
Albuquerque, NM
8.3
Based on 56 frontline employees who took The Breakroom Quiz
128th of 622 rated colleges and universities
Great coworkers
People enjoy working here
Good employer
Recommended by students
Paid breaks
Full-time
Re-posted 10 days ago
Job description
The Department of Family and Community Medicine seeks to hire a 0.25 Sr. Counselor/Licensed Therapist. This position will provide professional services and participant care for the UNM Research Program in Psychedelic Assisted Therapies. The individual will be a lead licensed therapist for the Group Assisted Psilocybin Assisted Therapy (GPAT)for PTSD. There is the potential to be involved with additional psychedelic assisted therapy studies.
GPAT is an innovative study of group Psilocybin Assisted Therapy using an affinity group model including veteran/first responders, women survivors of sexual trauma, and other groups. Preferred Qualifications include training and/or experience in psychedelic assisted therapy research, group therapy, and interest in working with individuals with PTSD and addiction. The model has been created to in alignment with a community engagement process. There is the potential for the therapist to participate in a lead role designing the therapeutic model and manual which will be in context of an FDA approved clinical trial protocol.
Duties and Responsibilities
1. Conduct therapy in accordance with approved research protocols. Working closely with the study MD and other study staff to implement the therapeutic aspects of protocol including preparatory sessions, medication administration sessions, and integration sessions. Ensure that therapy provided adheres to the research protocol.
2. Conduct therapy sessions in-person (individual and group) and virtual in preparation and for integration of the psilocybin sessions with psilocybin mushrooms.
3. Conduct full day psychedelic therapy medication sessions lasting about 8 hours and often occurring on weekends
4. Documentation of study visits, research questionnaires and therapy sessions in REDCap and study folders.
5. Follow-up phone calls and emails to study participants.
6. Completion of required checklists/progress notes and other source documents
7. Evaluating study participants for suicidal or homicidal risk and documenting clinical findings and decisions. Identity patients requiring therapeutic support.
8. Adherence to required completion deadlines for required University of New Mexico trainings and offered on learning central
9. Participate in study group meetings and conference calls
What University Of New Mexico employees say
Pay
Benefits
Hours and flexibility
Workplace
Get the full story on Breakroom